Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ARE 
Alexandria Real Estate Equities Inc (ARE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: ARE (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
13 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $96.79
1 Year Target Price $96.79
| 3 | Strong Buy |
| 1 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -32.98% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/17/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.84B USD | Price to earnings Ratio - | 1Y Target Price 96.79 |
Price to earnings Ratio - | 1Y Target Price 96.79 | ||
Volume (30-day avg) 13 | Beta 1.32 | 52 Weeks Range 65.12 - 114.45 | Updated Date 10/18/2025 |
52 Weeks Range 65.12 - 114.45 | Updated Date 10/18/2025 | ||
Dividends yield (FY) 6.99% | Basic EPS (TTM) -0.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.33% | Operating Margin (TTM) 20.36% |
Management Effectiveness
Return on Assets (TTM) 1.2% | Return on Equity (TTM) 0.78% |
Valuation
Trailing PE - | Forward PE 16.69 | Enterprise Value 27426325299 | Price to Sales(TTM) 4.15 |
Enterprise Value 27426325299 | Price to Sales(TTM) 4.15 | ||
Enterprise Value to Revenue 9.08 | Enterprise Value to EBITDA 16.21 | Shares Outstanding 170721043 | Shares Floating 154142744 |
Shares Outstanding 170721043 | Shares Floating 154142744 | ||
Percent Insiders 0.93 | Percent Institutions 95.89 |
Upturn AI SWOT
Alexandria Real Estate Equities Inc
Company Overview
History and Background
Alexandria Real Estate Equities, Inc. (ARE) was founded in 1994. It focuses on developing and leasing properties to the life science, technology, and agricultural industries. The company has grown from a small REIT to a leading provider of real estate for innovation clusters.
Core Business Areas
- Leasing: Leasing of laboratory and office space to life science, technology, and agtech companies.
- Development: Development and redevelopment of properties to meet the specific needs of tenants in target industries.
- Property Management: Management and maintenance of properties, including tenant services and building operations.
Leadership and Structure
The leadership team consists of executive officers such as the CEO, CFO, and other senior vice presidents. The organizational structure includes departments for leasing, development, finance, and property management.
Top Products and Market Share
Key Offerings
- Laboratory Space: Specialized lab spaces for life science companies. Market share is approximately 25% of lab space REITs, revenue not reported on a product basis. Competitors include Boston Properties (BXP), Healthpeak Properties (PEAK).
- Office Space: Office spaces designed for tech and agtech companies. Market share bundled with lab space, revenue not reported on a product basis. Competitors include Boston Properties (BXP), Healthpeak Properties (PEAK).
Market Dynamics
Industry Overview
The life science real estate industry is experiencing growth due to increasing research funding and demand for specialized facilities. Demand is driven by innovative companies. Biotech, Pharma and Tech giants are expanding.
Positioning
Alexandria is a leading provider of real estate in key innovation clusters. Its competitive advantages include its specialized expertise and its concentration in high-demand markets.
Total Addressable Market (TAM)
The global life science real estate market is expected to reach $74.38 billion by 2028. ARE is well-positioned to capture a significant share of this expanding market.
Upturn SWOT Analysis
Strengths
- Specialized expertise in life science real estate
- High-quality portfolio in key innovation clusters
- Strong relationships with leading life science companies
- Proven track record of development and redevelopment
Weaknesses
- Concentration in specific geographic areas
- Exposure to regulatory and economic changes in the life science industry
- High capital expenditures for development projects
Opportunities
- Expansion into new geographic markets
- Growth of the life science and technology industries
- Increasing demand for specialized laboratory and office space
- Development of new technologies and products
Threats
- Economic downturns
- Increased competition from other real estate developers
- Changes in government regulations
- Disruptions in the life science industry
Competitors and Market Share
Key Competitors
- Boston Properties (BXP)
- Healthpeak Properties (PEAK)
- Vornado Realty Trust (VNO)
Competitive Landscape
Alexandria's advantages include its specialization and expertise. Disadvantages include its concentration in specific geographic areas.
Major Acquisitions
OneFifteen
- Year: 2023
- Acquisition Price (USD millions): 30
- Strategic Rationale: Expansion into a new geography and focus on social impact (Behavioral Healthcare)
Growth Trajectory and Initiatives
Historical Growth: Alexandria has experienced significant growth in revenue and assets over the past decade, driven by expansion of its property portfolio and increased demand for its services.
Future Projections: Analysts project continued growth for Alexandria. These projections depend on real time estimates.
Recent Initiatives: Recent initiatives include expanding into new markets, developing new properties, and investing in new technologies.
Summary
Alexandria Real Estate Equities is a strong player in the life science real estate market, capitalizing on the growing demand for specialized lab and office spaces in innovation clusters. Its strengths lie in its expertise and high-quality portfolio. However, its concentration in specific regions and exposure to industry-specific risks require careful management. They should continue to expand their geographic footprint to increase revenues.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
- Market research reports
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market data is subject to change. Real time information is required for accuracy.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alexandria Real Estate Equities Inc
Exchange NYSE | Headquaters Pasadena, CA, United States | ||
IPO Launch date 1997-05-27 | CEO & Chief Investment Officer Mr. Peter M. Moglia | ||
Sector Real Estate | Industry REIT - Office | Full time employees 552 | Website https://www.are.com |
Full time employees 552 | Website https://www.are.com | ||
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of June 30, 2025, Alexandria has a total market capitalization of $25.7 billion and an asset base in North America that includes 39.7 million RSF of operating properties and 4.4 million RSF of Class A/A+ properties undergoing construction and one 100% pre-leased committed near-term project expected to commence construction in the next year. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.